BIOLASE Announces Successful Conclusion of Waterlase iPlus All Tissue Laser Trial

USA: BIOLASE, Inc., a dental laser manufacturer, has reported the successful completion of a trial program featuring the Waterlase iPlus All Tissue laser. The trial, led by an independent consultant and involving six leading U.S. dentists, focused on assessing the potential return on investment (ROI) and clinical adoption of this advanced technology. 

The outcome revealed unanimous satisfaction among the participating dentists, highlighting the desire to recommend the laser’s adoption across dental practices.

Dentist Feedback and Purchase Intent

Dr. Steve Fooshee, Advanced Laser Mentor/Educator Instructor, expressed satisfaction with the trial results, emphasizing the Waterlase iPlus laser’s value as a valuable tool for dentists. The positive reception from patients further solidified the laser’s significance in providing enhanced dental care. 

BIOLASE Enters US Skin Resurfacing Market with Launch of Waterlase Fractional Handpiece

Notably, all participants who evaluated the laser during this trial and a previous one at a dental service organization opted to purchase the unit, reflecting a high level of confidence in the technology.

The independent consultant and participating dentists highlighted the Waterlase iPlus laser’s advanced capabilities, enabling practitioners to perform procedures that were previously challenging. The laser’s versatility extends to various dental procedures, including tooth extractions, periodontal surgery, and cavity fillings. 

Additionally, the laser holds FDA approval for treating periodontal disease. The dentists’ unanimous decision to purchase the laser underscores its potential to enhance patient care and contribute to a higher standard of dentistry.

Significant ROI and Reduced Invasiveness

Dr. Russell Morrow, Chief Dental Officer for BIOLASE, emphasized the Waterlase iPlus laser’s role in advancing dental care. The laser’s precision, reduced invasiveness, and ability to minimize pain and bleeding during procedures position it as a significant advancement in dental technology. 

Dr. Morrow expressed enthusiasm for collaborating with dentists seeking to adopt this innovative technology, anticipating a substantial return on investment for their capital equipment purchase.

About BIOLASE

BIOLASE is a medical device company specializing in the development, manufacturing, marketing, and sale of laser systems in dentistry and medicine. Their proprietary laser products, incorporating numerous patented technologies, aim to provide superior performance with less pain and faster recovery times. With a global presence, BIOLASE has sold over 45,500 laser systems in more than 80 countries.

BIOLASE to Open Laser Dentistry Education Center for Dental Clinicians